Sotac Pharma.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE0O2D01012
NSEID: SOTAC
BSEID:

INR

123.10

-6.45 (-4.98%)

BSENSE

Dec 31

BSE+NSE Vol: 2400

{
  "main_header": {
    "sid": 1003827,
    "name": "Sotac Pharma.",
    "stock_name": "Sotac Pharma.",
    "full_name": "Sotac Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/sotac-pharma",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "123.10",
    "chg": -6.45,
    "chgp": "-4.98%",
    "dir": -1,
    "prev_price": "129.55",
    "mcapval": "143.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "SOTAC",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0O2D01012",
    "curr_date": "Dec 31",
    "curr_time": "",
    "bse_nse_vol": 2400,
    "exc_status": "Active",
    "traded_date": "Dec 31, 2025",
    "traded_date_str": "2025 12 31",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sotac-pharma-1003827-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Sotac Pharmaceuticals Ltd Plunges to Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sotac-pharmaceuticals-ltd-plunges-to-lower-circuit-amid-heavy-selling-pressure-3776448",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SotacPharmaceut_stocks_hitting_lower_circuit_3776448.png",
        "date": "2025-12-31 12:00:12",
        "description": "Sotac Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 31 Dec 2025, hitting its lower circuit limit with a maximum daily loss of 4.98%. The stock closed at ₹123.10, down ₹6.45 from the previous close, reflecting intense selling pressure and panic among investors amid unfilled supply on the trading floor."
      },
      {
        "title": "Sotac Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sotac-pharmaceuticals-ltd-is-rated-sell-3769911",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SotacPharmaceut_mojoScore_3769911.png",
        "date": "2025-12-25 15:12:04",
        "description": "Sotac Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Why is Sotac Pharma. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-sotac-pharma-fallingrising-3749697",
        "imagepath": "",
        "date": "2025-12-06 01:45:32",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Movement and Market Context</strong></p>\n<p>The stock’s recent price action reflects a significant underperformance relative to both its sector and broader market indices. Over the past week, Sotac Pharma’s shares have declined by 6.46%, markedly worse than the Sensex’s marginal 0.06% dip during the same period. This divergence suggests that the stock is facing specific pressures not affecting the wider market. Furthermore, the one-month return shows a slight negative movement of 0.23%, while the Sensex has gained 2.30%, reinforcing the notion of short-term weakness.</p>\n<p>On the day in question, the stock underperformed its sector by 4.78%, indicating that sectoral factors alone do not explain the decline. The share price currently trades above its 20-day, 50-day, 100-day,..."
      },
      {
        "title": "Sotac Pharmaceuticals Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sotac-pharmaceuticals-hits-lower-circuit-amid-heavy-selling-pressure-3748952",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SotacPharmaceut_stocks_hitting_lower_circuit_3748952.png",
        "date": "2025-12-05 12:00:07",
        "description": "Sotac Pharmaceuticals Ltd witnessed a sharp decline on 5 Dec 2025, hitting its lower circuit price limit as intense selling pressure gripped the stock. The pharmaceutical and biotechnology company’s shares closed at ₹129.55, marking a maximum daily loss of 4.99%, underperforming both its sector and the broader market indices."
      },
      {
        "title": "Sotac Pharmaceuticals Faces Intense Selling Pressure Amid Market Downturn",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sotac-pharmaceuticals-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3748879",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SotacPharmaceut_only_sellers_3748879.png",
        "date": "2025-12-05 11:36:11",
        "description": "Sotac Pharmaceuticals Ltd experienced a pronounced decline on 5 Dec 2025, with the stock registering a sharp fall of 4.99% in a session dominated exclusively by sell orders. This extreme selling pressure, coupled with the absence of buyers, signals distress selling and highlights the challenges facing the company within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Sotac Pharma. Sees Revision in Market Assessment Amid Mixed Evaluation Metrics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sotac-pharma-upgraded-from-strong-sell-to-hold-by-marketsmojo-3746577",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SotacPharma_mojoScore_3746577.png",
        "date": "2025-12-04 11:08:06",
        "description": "Sotac Pharma., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market assessment, reflecting shifts across key evaluation parameters. This development comes amid a backdrop of steady stock returns and a complex financial profile, prompting investors to reassess the company’s position within its sector."
      },
      {
        "title": "How has been the historical performance of Sotac Pharma.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-sotac-pharma-3736026",
        "imagepath": "",
        "date": "2025-11-28 22:44:21",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profitability Trends</strong></p>\n<p>Over the five-year period ending March 2025, Sotac Pharma. saw its net sales rise substantially from ₹28.60 crores in 2020 to ₹96.99 crores in 2025. This represents a more than threefold increase, reflecting the company’s expanding market presence and operational scale. However, the revenue peaked in 2024 at ₹103.83 crores before a slight dip in 2025, indicating some volatility in sales performance.</p>\n<p>Operating profit margins have improved markedly, with the operating profit excluding other income increasing from a modest 6.5% margin in 2020 to a robust 14.07% in 2025. This improvement underscores enhanced operational efficiency and cost management. The company’s profit before tax surged from a marginal ₹0.36 crores in 2020 to ₹11.12 cror..."
      },
      {
        "title": "Sotac Pharmaceuticals Hits Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sotac-pharmaceuticals-hits-upper-circuit-amid-strong-buying-pressure-3717637",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SotacPharmaceut_stocks_hitting_upper_circuit_3717637.png",
        "date": "2025-11-20 10:00:27",
        "description": "Sotac Pharmaceuticals Ltd witnessed a significant surge in its share price on 20 Nov 2025, hitting the upper circuit limit of 5.0% to close at ₹131.25. This movement reflects robust buying interest and a notable outperformance relative to its sector and benchmark indices, signalling heightened investor enthusiasm in the Pharmaceuticals & Biotechnology space."
      },
      {
        "title": "Sotac Pharmaceuticals Hits Lower Circuit Limit, Closes at Rs 122.55",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sotac-pharmaceuticals-hits-lower-circuit-limit-closes-at-rs-12255-3707698",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SotacPharmaceut_stocks_hitting_lower_circuit_3707698.png",
        "date": "2025-11-17 14:00:13",
        "description": "Sotac Pharmaceuticals Ltd faced notable trading activity as its stock reached the lower circuit limit, closing at Rs 122.55. The stock's performance lagged behind the sector, with a total traded volume of 0.024 lakh shares. Its positioning relative to moving averages indicates volatility typical of microcap stocks."
      }
    ],
    "total": 310,
    "sid": "1003827",
    "stock_news_url": "https://www.marketsmojo.com/news/sotac-pharmaceuticals-1003827"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sotac Pharmaceuticals Ltd has declared <strong>1%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sotac Pharmaceuticals Ltd Plunges to Lower Circuit Amid Heavy Selling Pressure

2025-12-31 12:00:12

Sotac Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 31 Dec 2025, hitting its lower circuit limit with a maximum daily loss of 4.98%. The stock closed at ₹123.10, down ₹6.45 from the previous close, reflecting intense selling pressure and panic among investors amid unfilled supply on the trading floor.

Sotac Pharmaceuticals Ltd is Rated Sell

2025-12-25 15:12:04

Sotac Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with the latest insights into its performance and outlook.

Why is Sotac Pharma. falling/rising?

2025-12-06 01:45:32

Short-Term Price Movement and Market Context

The stock’s recent price action reflects a significant underperformance relative to both its sector and broader market indices. Over the past week, Sotac Pharma’s shares have declined by 6.46%, markedly worse than the Sensex’s marginal 0.06% dip during the same period. This divergence suggests that the stock is facing specific pressures not affecting the wider market. Furthermore, the one-month return shows a slight negative movement of 0.23%, while the Sensex has gained 2.30%, reinforcing the notion of short-term weakness.

On the day in question, the stock underperformed its sector by 4.78%, indicating that sectoral factors alone do not explain the decline. The share price currently trades above its 20-day, 50-day, 100-day,...

Sotac Pharmaceuticals Hits Lower Circuit Amid Heavy Selling Pressure

2025-12-05 12:00:07

Sotac Pharmaceuticals Ltd witnessed a sharp decline on 5 Dec 2025, hitting its lower circuit price limit as intense selling pressure gripped the stock. The pharmaceutical and biotechnology company’s shares closed at ₹129.55, marking a maximum daily loss of 4.99%, underperforming both its sector and the broader market indices.

Sotac Pharmaceuticals Faces Intense Selling Pressure Amid Market Downturn

2025-12-05 11:36:11

Sotac Pharmaceuticals Ltd experienced a pronounced decline on 5 Dec 2025, with the stock registering a sharp fall of 4.99% in a session dominated exclusively by sell orders. This extreme selling pressure, coupled with the absence of buyers, signals distress selling and highlights the challenges facing the company within the Pharmaceuticals & Biotechnology sector.

Sotac Pharma. Sees Revision in Market Assessment Amid Mixed Evaluation Metrics

2025-12-04 11:08:06

Sotac Pharma., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market assessment, reflecting shifts across key evaluation parameters. This development comes amid a backdrop of steady stock returns and a complex financial profile, prompting investors to reassess the company’s position within its sector.

How has been the historical performance of Sotac Pharma.?

2025-11-28 22:44:21

Revenue and Profitability Trends

Over the five-year period ending March 2025, Sotac Pharma. saw its net sales rise substantially from ₹28.60 crores in 2020 to ₹96.99 crores in 2025. This represents a more than threefold increase, reflecting the company’s expanding market presence and operational scale. However, the revenue peaked in 2024 at ₹103.83 crores before a slight dip in 2025, indicating some volatility in sales performance.

Operating profit margins have improved markedly, with the operating profit excluding other income increasing from a modest 6.5% margin in 2020 to a robust 14.07% in 2025. This improvement underscores enhanced operational efficiency and cost management. The company’s profit before tax surged from a marginal ₹0.36 crores in 2020 to ₹11.12 cror...

Sotac Pharmaceuticals Hits Upper Circuit Amid Strong Buying Pressure

2025-11-20 10:00:27

Sotac Pharmaceuticals Ltd witnessed a significant surge in its share price on 20 Nov 2025, hitting the upper circuit limit of 5.0% to close at ₹131.25. This movement reflects robust buying interest and a notable outperformance relative to its sector and benchmark indices, signalling heightened investor enthusiasm in the Pharmaceuticals & Biotechnology space.

Sotac Pharmaceuticals Hits Lower Circuit Limit, Closes at Rs 122.55

2025-11-17 14:00:13

Sotac Pharmaceuticals Ltd faced notable trading activity as its stock reached the lower circuit limit, closing at Rs 122.55. The stock's performance lagged behind the sector, with a total traded volume of 0.024 lakh shares. Its positioning relative to moving averages indicates volatility typical of microcap stocks.